3CEFALU W T, BINDRA S. Inhaled insulin : a novel route for insulin delivery [ J ]. Expert Opin Investig Drugs, 2002,11 ( 5 ) : 687- 691.
4LENZER J. Inhaled insulin is approvd in Europe and United States[J]. BMJ,2006,332:321.
5HARSCH I A. Inhaled insulins:their potential in the treatment of diabetes mellitus [J]. Treat Endoerinol,2005,4 : 131-138.
6ANONYMOUS. Puhnonary medicine : Novo nordisk, aradigm start phase Ⅲ studies of AERx insulin delivery system [ J ]. Diabetes Week, 2002,15.
7RUBSAMEN R M,LLOYD L. Method of administration of insulin:The United States,5672581 [ P]. 1997-09-30.
8JOHN R W. Inhaled insulin: an overview [ J ]. Clin Diabetes, 2001,19 : 13-16.
9DAVID A E, JUSTIN H. Large porous particles for puhnonary drug delivery[ J ]. Sciences, 1997,276 ( 20 ) : 1868 -1871.
10ROSENSTOCK J,BAUGHMAN R A,RIVERA S T,et al. A randomized, double-blind, placebo controlled study of the efficacy and safety of inhaled Technophere insulin in patients with type 2 diabetes ( T2 DM) [ J ]. Diabetes,2005,54.
4Durra C, Curran MP. Inhaled human insulin ( Exubera ) : a review of its use in adult patients with diabetes mellitus. Drugs,2006, 66:1013-1032.
5Patton JS, Bukar JG, Eldon MA. Clinical pharmacokinetics and pharmacodynamica of inhaled insulin. Clin Pharmacokinet, 2004,43 : 781-801.
6Scholtz HE, Pretorius SG, Wessels DH, et al. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia, 2005,48 : 1988-1995.
7Kapitza C, Hompesch M, Scharling B, et al. Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin. Diabetes Technol Ther,2004, 6: 466-472.
8Quattrin T, Belanger A, Bohannon NJV, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes, results of a 6-month,randomized, comparative trial. Diabetes Care,2004, 27:2622-2627.
4Cheng YS, Zhou Y, Chen BT. Particle deposition in a cast of human oral airways [J].Aerosol Sci Technol, 1999, 31 (4) : 286-300.
5Anderson JD Jr. Computational Fluid Dynamics: the Basics with Applications [M]. New York: McGraw-Hill, 2002: 4.
6Martonen TB, Zhang Z, Yu G, et al. Three-dimensional computer modeling of the human upper respiratory tract[J]. Cell Biochem Biophys, 2001, 35 (3) : 255-261.
7Stapleton KW, Guentsch E, Hoskinson MK, et al. On the suitability of K-ε turbulence modeling for aerosol deposition in the mouth and throat: a comparison with experiment [J]. JAerosol Sci, 2000, 31 (6) : 739-749.
8Li Z, Kleinstreuer C, Zhang Z. Particle deposition in the human tracheobronchial airways due to transient inspiratory flow patterns[J]. JAerosol Sci, 2007, 38 (6) : 625-644.
9Zhang Z, Kleinstreuer C, Kim CS. Micro-particle transport and deposition in a human oral airway model [J].JAerosol Sci, 2002, 33 (12): 1635-1652.
10Martonen TB, Zhang Z, Yue G, et al. 3-D Particle transport within the human upper respiratory tract [J].JAerosol Sci, 2002, 33 (8) : 1095-1110.
